AshbyM, StoffellB.Therapeutic ration and defined phases: proposal of ethical framework for palliative care. Br Med J1991; 302: 1322–1324.
2.
Federal register1983; 48 (243):56008–56036.
3.
MillerRJ. Predicting survival in the advanced cancer patient. Henry Ford Hosp Med J1991; 39 (2):81–84.
4.
ParkesCM. Accuracy of predictions in later stages of cancer. Br Med J1972; 2: 29–31.
5.
EvansC, McCarthyM.Prognostic uncertainty in terminal care: can the Karnofsky Index help?Lancet1985; 25: 1204–1206.
6.
Heyse-MooreLH, Johnson-BellVE. Can doctors accurately predict the life expectancy of patients with terminal cancer?Palliat Med1987; 1: 165–166.
7.
KarnofskyDA. BurchenalJH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeodCM (ed). Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949; 191–205.
8.
YatesJW, ChalmerB, McKegneyP.Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer1980; 45: 2220–2224.
9.
MorV, LalibertéL, MorrisJN, WeinmannM.The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer1984; 53: 2002–2007.
10.
ReubenDB, MorV, HirisJ.Clinical symptoms and length of survival in patients with terminal cancer. Arch Int Med1988; 148: 1586–1591.
11.
StanleyK.Prognostic factors for survival in patients with inoperable lung cancers. J Natl Cancer Institute1980; 65: 25.
12.
Heyse-MooreLH, RossV, MulleeMA. How much of a problem is dyspnea in advanced cancer?Palliat Med1991; 5: 20–26.
13.
MorrisJN, SuissaS, SherwoodS, WrightSM, GreerD.Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis1986; 39: 47.
14.
MorrisJN. SherwoodS.Quality of life of cancer patients at different stages in the disease trajectory. J Chronic Dis1987; 40: 545.
15.
Addington-HallJM, MacDonaldLD, AndersonHR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?Br J Cancer1990; 62: 695–699.
16.
SpitzerWO, DobsonAL, Hall. Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. J Chronic Dis1981; 34: 585.
17.
Le CesneA, Le ChevalierT, CailleP, CvitkovicE. Metastases de cancers a point de depart inconnu. Enseignement de 302 autopsies. La Presse Med1991; 20 (29):1369–1373.
18.
RalstonST, GallacherSJ, PatelU, CampbellJ, BoyleIT. Cancer-associated hypercalcemia: morbidity and mortality: clinical experience in 126 treated patients. Ann Int Med1990; 112: 499–504.
19.
HermannFR, SafranC, LevkoffSF, KennethI.Serum albumin level on admission as a predictor of death, length of stay and readmission. Arch Int Med1992; 152 (1):125–130.
20.
ConstansT, BruyèreA, GrabB, RapinCH. PINI as mortality index in hospitalized elderly patients. Research note. Int J Vit Nutr Res1992; 62 (2):191.
21.
RomagnoliA, RapinCH. Valeur pronostique de certains paramètres biologiques chez des sujets ages hospitalises. Age Nutrition1991; 2 (3):130–136.
22.
IngenbleekY, CarpentierYA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vit Nutr Res1985; 55: 91–101.
23.
CassilethBR, LuskEJ, MillerDS, BrownLL, MillerC.Psychosocial correlates of survival in advanced malignant disease?N Engl J Med1985; 312 (24):1551–1555.
24.
SpiegelD, BloomJR, KraemerHC, GottheilE.Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet1989; 14: 888–891.
25.
CassilethBR, LuskEJ, GuerryDupont. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med1991; 324: 1180–1185.
